The internationally active life science company Eppendorf, headquartered in Hamburg, Germany, has completed its conversion to the European legal form Societas Europaea (SE) as of October 19, 2021.
"We are convinced that we have taken the right step at the right time with this modern legal form, which is very common in large family-owned companies," said Eva van Pelt and Dr. Peter Fruhstorfer, Co-CEOs of Eppendorf SE. "The company's name as a European public limited company is a clear signal that even more strongly expresses Eppendorf's global corporate culture. In addition, the new legal form shows that Eppendorf is an international company and that national borders play less and less of a role for us."
The new company name as Eppendorf SE demonstrates the company's further development into a modern, progressive, and internationally active European company, the CEOs added. Also, it provides important support that will enable Eppendorf to continue its global success course even more effectively, they said.
The conversion into a Societas Europaea will not result in any changes to the company's structure. Management Board and Supervisory Board members continue to work for Eppendorf SE. Eppendorf's Group headquarters will remain in Hamburg, Germany, and the character of an independent familyowned company will be preserved.
More News
Mindpeak Earns IVDR Certification
Mindpeak, a leading developer of AI-powered software for digital pathology, announced it has achieved certification under the EU In Vitro Diagnostic Medical Devices Regulation (IVDR). ...
Read more …
HALRIC Strengthens Life Science Connections in Northern Europe
After three years, Life Science Nord has issued a positive assessment of the Interreg project HALRIC – Hanseatic Life Science Research Infrastructure Consortium. The project’s ...
Read more …
#NEWatLSN: Galagos
We are delighted to welcome Galagos as a new member of Life Science Nord e.V.! The founding team answered questions about the company’s initial goals, ...
Read more …